amiodarone has been researched along with Eye Diseases in 25 studies
Amiodarone: An antianginal and class III antiarrhythmic drug. It increases the duration of ventricular and atrial muscle action by inhibiting POTASSIUM CHANNELS and VOLTAGE-GATED SODIUM CHANNELS. There is a resulting decrease in heart rate and in vascular resistance.
amiodarone : A member of the class of 1-benzofurans that is 1-benzofuran substituted by a butyl group at position 2 and a 4-[2-(diethylamino)ethoxy]-3,5-diiodobenzoyl group at position 3. It is a cardiovascular drug used for the treatment of cardiac dysrhythmias.
Eye Diseases: Diseases affecting the eye.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Thyroid disorders and eye diseases are interrelated through several mechanisms thus, awareness of this relation has a great impact on early diagnosis and treatment." | 5.05 | Thyroid and Eye: Where They Meet in Clinical Practice. ( El-Eshmawy, MM; Shahin, M, 2020) |
| " In particular, we reviewed the effects of cyanosis, coarctation of the aorta, endocarditis, and the side effects of Sildenafil and Amiodarone." | 4.98 | The eye in CHD. ( Celermajer, D; Cordina, R; Liew, G; McCluskey, P; Nasir-Ahmad, S, 2018) |
| "Amiodarone, an anti-ischaemic and anti-arrhythmic drug, has been the object of numerous studies and seems to be highly effective in the treatment of severe ventricular arrhythmias on dilated cardiomyopathies, as well as of hypertrophic or ischaemic heart diseases." | 4.78 | [Does amiodarone have a benefit effect on mortality?]. ( Kahn, JC; Pathé, M, 1991) |
| "Numerous systemic drugs produce adverse effects that involve the eye." | 2.38 | Ocular side effects of selected systemic drugs. ( Jaanus, SD, 1992) |
| "Amiodarone has a reduced clearance rate, large volume of distribution, low bioavailability and a long half-life that may last 2 months in patients receiving short-term therapy." | 2.37 | Amiodarone: electrophysiologic actions, pharmacokinetics and clinical effects. ( Heger, JJ; Prystowsky, EN; Zipes, DP, 1984) |
| " Many of these adverse side effects can be greatly reduced or prevented with close monitoring of patients." | 1.31 | Ocular toxicity of systemic medications: a case series. ( To, TQ; Townsend, JC, 2000) |
| " It is suggested that patients taking amiodarone in high dosage for long periods have their eyes and retinal function monitored." | 1.27 | Amiodarone-induced ultrastructural changes in human eyes. ( Ghosh, M; McCulloch, C, 1984) |
| "Control of arrhythmias was satisfactory in all 12 evaluable patients, when the serum amiodarone level exceeded 1." | 1.27 | Serum concentrations of amiodarone during long term therapy. Relation to dose, efficacy and toxicity. ( Bircher, J; Galeazzi, RL; Remund, H; Stäubli, M; Studer, H, 1983) |
| "An unusual case of recurrence of amiodarone pulmonary toxicity is described." | 1.27 | [Recurrent alveolitis caused by amiodarone]. ( Ciani, F; Padrini, R; Pandullo, C; Pivotti, F; Scardi, S, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 15 (60.00) | 18.7374 |
| 1990's | 5 (20.00) | 18.2507 |
| 2000's | 2 (8.00) | 29.6817 |
| 2010's | 2 (8.00) | 24.3611 |
| 2020's | 1 (4.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nasir-Ahmad, S | 1 |
| Cordina, R | 1 |
| Liew, G | 1 |
| McCluskey, P | 1 |
| Celermajer, D | 1 |
| El-Eshmawy, MM | 1 |
| Shahin, M | 1 |
| van Erven, L | 1 |
| Schalij, MJ | 1 |
| Imaizumi, M | 1 |
| Ikebe, T | 1 |
| Ikewaki, J | 1 |
| Nakatsuka, K | 1 |
| Lubbe, WF | 1 |
| Mercer, CJ | 1 |
| Friocourt, P | 1 |
| Coumel, P | 1 |
| Zipes, DP | 1 |
| Prystowsky, EN | 1 |
| Heger, JJ | 1 |
| Ingram, DV | 1 |
| Ghosh, M | 1 |
| McCulloch, C | 1 |
| Yin, SY | 1 |
| Perry, HD | 1 |
| Stäubli, M | 1 |
| Bircher, J | 1 |
| Galeazzi, RL | 1 |
| Remund, H | 1 |
| Studer, H | 1 |
| Clemett, RS | 1 |
| MacKintosh, HT | 1 |
| Banerjee, S | 1 |
| James, CB | 1 |
| Incalzi, RA | 1 |
| Gemma, A | 1 |
| Carbonin, PU | 1 |
| Riihelä, K | 1 |
| Mäntyjärvi, M | 1 |
| To, TQ | 1 |
| Townsend, JC | 1 |
| Canta, LR | 1 |
| Jaanus, SD | 1 |
| Pathé, M | 1 |
| Kahn, JC | 1 |
| Taylor, F | 1 |
| Costa, C | 1 |
| Visalli, N | 1 |
| Natoli, A | 1 |
| Fossati, C | 1 |
| Disertori, M | 1 |
| Inama, G | 1 |
| Scardi, S | 1 |
| Ciani, F | 1 |
| Pandullo, C | 1 |
| Padrini, R | 1 |
| Pivotti, F | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| aMsa and amiOdarone Study in cArdiaC Arrest[NCT04997980] | 500 participants (Anticipated) | Observational | 2015-01-01 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
9 reviews available for amiodarone and Eye Diseases
| Article | Year |
|---|---|
The eye in CHD.
Topics: Adult; Amiodarone; Aortic Coarctation; Cyanosis; Endocarditis; Eye Diseases; Heart Defects, Congenit | 2018 |
Thyroid and Eye: Where They Meet in Clinical Practice.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Antithyroid Agents; Diabetic Retinopathy; Eye; Eye Dise | 2020 |
[Drug-induced visual disturbance].
Topics: Amiodarone; Anti-Asthmatic Agents; Antimalarials; Antitubercular Agents; Antiviral Agents; Chloroqui | 2007 |
[Side effects of amiodarone].
Topics: Amiodarone; Benzofurans; Brain Diseases; Cardiovascular Diseases; Eye Diseases; Humans; Skin Disease | 1983 |
Amiodarone: electrophysiologic actions, pharmacokinetics and clinical effects.
Topics: Administration, Oral; Amiodarone; Animals; Arrhythmias, Cardiac; Atrioventricular Node; Benzofurans; | 1984 |
[Ocular findings associated to the use of amiodarone].
Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cornea; Eye Diseases; Female; | 1996 |
Ocular side effects of selected systemic drugs.
Topics: Amiodarone; Anti-Inflammatory Agents; Antirheumatic Agents; Chloroquine; Chlorpromazine; Drug Intera | 1992 |
[Does amiodarone have a benefit effect on mortality?].
Topics: Amiodarone; Arrhythmias, Cardiac; Death, Sudden, Cardiac; Eye Diseases; France; Heart Arrest; Humans | 1991 |
[Collateral effects of an anti-arrhythmic agent: amiodarone].
Topics: Amiodarone; Benzofurans; Chemical and Drug Induced Liver Injury; Eye Diseases; Humans; Hyperthyroidi | 1985 |
1 trial available for amiodarone and Eye Diseases
| Article | Year |
|---|---|
[Extracardiac side effects of Aminodarone].
Topics: Amiodarone; Arrhythmias, Cardiac; Benzofurans; Clinical Trials as Topic; Drug Evaluation; Eye Diseas | 1986 |
15 other studies available for amiodarone and Eye Diseases
| Article | Year |
|---|---|
Amiodarone: an effective antiarrhythmic drug with unusual side effects.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Drug Administration Schedule; Drug Eruptio | 2010 |
Amiodarone: its side effects, adverse reactions and dosage schedules.
Topics: Amiodarone; Benzofurans; Central Nervous System Diseases; Drug Administration Schedule; Eye Diseases | 1982 |
Ocular effects in long-term amiodarone therapy.
Topics: Amiodarone; Benzofurans; Corneal Diseases; Eye Diseases; Humans; Vision Disorders | 1983 |
Amiodarone-induced ultrastructural changes in human eyes.
Topics: Amiodarone; Benzofurans; Corneal Diseases; Eye; Eye Diseases; Female; Humans; Male; Retinal Diseases | 1984 |
[Clinical observation on ocular complications after administration of amiodarone in control of arrhythmias].
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Eye Diseases; Female; Humans; Iodides; M | 1982 |
Drugs and toxins.
Topics: Adult; Amiodarone; Child; Conjunctivitis; Corneal Diseases; Eye Diseases; Female; Humans; Idoxuridin | 1983 |
Serum concentrations of amiodarone during long term therapy. Relation to dose, efficacy and toxicity.
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Corneal Diseases; Eye Diseases; Female; | 1983 |
Drug induced ocular lipoidosis.
Topics: Adolescent; Adult; Aged; Amiodarone; Benzofurans; Cataract; Color Vision Defects; Corneal Diseases; | 1982 |
Amiodarone and dysthyroid eye disease.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Eye Diseases; Humans; Male; Thyroid Diseases | 1996 |
Amiodarone after myocardial infarction: EMIAT and CAMIAT trials.
Topics: Amiodarone; Anti-Arrhythmia Agents; Clinical Trials as Topic; Eye Diseases; Humans; Lung Diseases | 1997 |
Ocular toxicity of systemic medications: a case series.
Topics: Adult; Aged; Amiodarone; Cataract; Corneal Diseases; Eye Diseases; Female; Glaucoma; Humans; Isoniaz | 2000 |
From unwanted side-effects of drugs to an ophthalmological pharmacotherapy.
Topics: Amiodarone; Eye Diseases; Humans; Iatrogenic Disease; Registries | 1977 |
Drugs affecting the eye.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Amiodarone; Anti-Inflammatory Agents; Antipsychotic Agen | 1985 |
[Adverse effects during chronic treatment with low-dose amiodarone].
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Child; Drug Interactions; Eye Diseases; | 1985 |
[Recurrent alveolitis caused by amiodarone].
Topics: Amiodarone; Benzofurans; Eye Diseases; Female; Humans; Hyperthyroidism; Hypothyroidism; Middle Aged; | 1986 |